pbm play accord view main take-away
confer call pbm earn ramp go accord plan
shown detail pbm analysis/bridg tabl figur page pbm
earn mid-to-high single-digit y/i figur driven larg
part suppli chain initi lower cost drug procur etc combin
narrow pbm earn guidanc unchang midpoint investor
higher confid deliv full-year health servic
segment result follow thursday solid earn beat ci stock finish day
vs peer think stock would higher
today ep commentari seem somewhat temper expect
color
outlook ci expect underli ep growth
adjust ep baselin impli ep vs prior
consensu lower midpoint note earlier see detail
outlook octob delta larg explain
conservat pyd futur share repurchas hif headwind vs core
oper said investor expect higher underli ep growth
given pace ci buy back share bn ytd
ramp sg synergi benefit debt reduct note compani
call margin normal individu busi think margin
run high end target rang ci histori
guid conserv note initi ep guid vs current
possibl similar stori may play
reiter ow follow today result rais ep estim
trim ep modestli ep
conserv around hif similar trend
earlier year maintain ow rate pt price-to-earnings new ep
ci quarterli annual ep usd
return equiti ttm
link barclay live interact chart
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight continu leverag
strength control medic cost continu
gain market share commerci busi
return industri growth medicar
upsid case reflect favor medic
cost trend outlook higher expect share
gain commerci segment
downsid case reflect risk associ
increas cost trend aggress commerci price
lower expect commerci growth
ci investor day bridg esrx ebitda guidanc project health servic earn growth
ci investor day present note includ re-segment cigna deliveri express script part adjust
pbm commentari earn call
recal provid roll-forward full year earn back investor day kind
basi way think would first half earn mid-singl
digit compar basi first half make adjust re-segment
like back half expect earn mid- high singl digit
compar basi pull piec togeth get result consist guid
segment overal cours year tighten earn releas billion
ern consolid oper metricsadjust incom oper revenu expens tax oper metricsadjust incom oper pre-taxhealth servic pre-tax incom medic pre-tax incom custom pharmaci bn bnmedic barclay
 financi model consolid incom statement pharmaci invest adjust changetot expensesmed benefit medic servic excl intang oper incom loss attribut includ margin expens adjust margin tax net incom margin share fulli barclay
integr medic invest oper loss attribut adjust margin assumptionsfe revenenu loss subject py sg servic segment pharmaci invest servic oper loss attribut expens adjust margin barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
